Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Centre for Rehabilitation Research in Oxford (RRIO) led by Professor Sallie Lamb of NDORMS has been awarded £2 million by the National Institute for Health Research (NIHR) to look at improving the management of lower back pain in older people.

The Centre for Rehabilitation Research in Oxford (RRIO) lead by Professor Sallie Lamb of NDORMS has been awarded £2 million by the National Institute for Health Research (NIHR) to look at improving the management of lower back pain in older people.

Lower back pain is now recognised as the leading disabling condition in the world, with over 70% of people suffering with it in their lifetime. Older people in particular are at higher risk of having the most serious forms of lower back pain, leading to mobility decline and falls, as well as frailty and loss of independence – a key concern for this age group.

Despite this, lower back pain in older people is often ignored, missed or mismanaged in primary care. Both patients and their GPs may dismiss treatment for lower back pain, instead accepting it as part of ageing and prioritising the treatment of other health conditions. In addition, although there is a large amount of research on back pain, older people are often excluded from these studies.

The BOOST programme of research (Better Outcomes for Older People with Spinal Trouble) will help primary health care clinicians, patients and their carers recognise when to prioritize the treatment of back pain , and to explore and hopefully counter prejudices held by older people and clinicians.  It will also evaluate a physiotherapy programme for people with neurogenic claudication, a condition arising from ageing changes within the spine, which is common in older people and can severely limit their ability to walk and stand.  

Dr Esther Williamson, NDORMS Research Fellow and project lead says: "Remaining independent is the key concern for older people. Through this work we want to develop evidence based treatment strategies as well as an improved understanding of prognosis and greater knowledge about back pain in older people. By developing effective treatments we hope to reduce pain but also have an impact on broader health outcomes, helping older people to remain active and independent and preventing falls and frailty."

If you’d like to find out more about this study or be involved, please contact Esther and the BOOST research team at BOOST@ndorms.ox.ac.uk

 

Similar stories

3,400 different medicines used globally to treat COVID-19

Main Statistics and epidemiology

Insufficient data, and misleading recommendations led to significant early heterogeneity in global COVID-19 patient management, according to recent BMJ study

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

The role of mAbs (neutralising monoclonal antibodies) in the fight against COVID-19

Main Research

Neutralising mAbs, a form of anti-viral medicine, are being explored as an attractive option to treat symptoms of COVID-19 and in some cases prevent infection. But what are the pros and cons of this type of treatment and what should regulators consider before granting approval?

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.